SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1068)3/17/1998 11:11:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Bruce Galton,

It has been a year and a half since the Immunex IL-1 settlement. Since then the following has occurred>>

Shareholder value at Immunex has INCREASED 450%
Shareholder value at Cistron has DECREASED 60%

With over $13 million in total cash.
Very little cash burn rate.
No large downward selling pressure left on the stock.

Why are you ALLOWING the stock to trade at bankruptcy type levels?



To: Steve Harmon who wrote (1068)3/17/1998 11:26:00 AM
From: Rudy Saucillo  Read Replies (2) | Respond to of 2742
 
Yeah, Steve. I noticed yesterday. This is good since the business plan has clearly changed.

Investors are certainly due an update. Did the BlueStone contract result in active negotiations with any outside business entities???

Rudy


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News